Literature DB >> 7039828

Specificity and mechanism(s) of promoter inhibitors in multistage promotion.

T J Slaga, S M Fischer, C E Weeks, K Nelson, M Mamrack, A J Klein-Szanto.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 7039828

Source DB:  PubMed          Journal:  Carcinog Compr Surv        ISSN： 0147-4006


× No keyword cloud information.
  6 in total

1.  Computer-assisted molecular modeling of tumor promoters: rationale for the activity of phorbol esters, teleocidin B, and aplysiatoxin.

Authors:  A M Jeffrey; R M Liskamp
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

Review 2.  Clinical implications of current studies in carcinogenesis.

Authors:  B A Ponder
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

3.  A definitive role of ornithine decarboxylase in photocarcinogenesis.

Authors:  N Ahmad; A C Gilliam; S K Katiyar; T G O'Brien; H Mukhtar
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

4.  Cepharanthine inhibits two-stage tumor promotion by 12-O-tetradecanoylphorbol 13-acetate and mezerein on skin tumor formation in mice initiated with 7,12-dimethylbenz[a]anthracene.

Authors:  K Yasukawa; M Takido; M Takeuchi; M Akasu; S Nakagawa
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

5.  Inflammation, oxidative DNA damage, and carcinogenesis.

Authors:  J G Lewis; D O Adams
Journal:  Environ Health Perspect       Date:  1987-12       Impact factor: 9.031

Review 6.  Oxidation of DNA bases by tumor promoter-activated processes.

Authors:  K Frenkel
Journal:  Environ Health Perspect       Date:  1989-05       Impact factor: 9.031
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.